Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Financial giants have made a conspicuous bearish move on Johnson & Johnson. Our analysis of options history for Johnson & Johnson (NYSE:JNJ) revealed 10 unusual trades.
Delving into the details, we found 20% of traders were bullish, while 70% showed bearish tendencies. Out of all the trades we spotted, 4 were puts, with a value of $117,603, and 6 were calls, valued at $283,044.
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $135.0 to $170.0 for Johnson & Johnson over the last 3 months.
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Johnson & Johnson's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Johnson & Johnson's significant trades, within a strike price range of $135.0 to $170.0, over the past month.
Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
---|---|---|---|---|---|---|---|---|---|---|---|
JNJ | CALL | TRADE | BEARISH | 12/18/26 | $15.05 | $13.9 | $14.3 | $170.00 | $100.1K | 15 | 70 |
JNJ | CALL | TRADE | BEARISH | 08/16/24 | $5.6 | $5.45 | $5.5 | $155.00 | $55.0K | 9.8K | 120 |
JNJ | CALL | SWEEP | BEARISH | 01/17/25 | $21.85 | $21.45 | $21.5 | $140.00 | $36.5K | 623 | 29 |
JNJ | PUT | SWEEP | BEARISH | 09/20/24 | $2.42 | $2.39 | $2.4 | $155.00 | $36.4K | 3.8K | 202 |
JNJ | CALL | SWEEP | BEARISH | 09/20/24 | $1.67 | $1.66 | $1.67 | $165.00 | $35.9K | 7.9K | 481 |
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.
Having examined the options trading patterns of Johnson & Johnson, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $178.8.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Johnson & Johnson, Benzinga Pro gives you real-time options trades alerts.
Posted In: JNJ